AR053688A1 - Composicion farmaceurtica y su uso - Google Patents

Composicion farmaceurtica y su uso

Info

Publication number
AR053688A1
AR053688A1 ARP060100758A ARP060100758A AR053688A1 AR 053688 A1 AR053688 A1 AR 053688A1 AR P060100758 A ARP060100758 A AR P060100758A AR P060100758 A ARP060100758 A AR P060100758A AR 053688 A1 AR053688 A1 AR 053688A1
Authority
AR
Argentina
Prior art keywords
pharmaceutically acceptable
effective amount
therapeutically effective
hydrocortisone
pharmaceurtical
Prior art date
Application number
ARP060100758A
Other languages
English (en)
Inventor
Celia Palacin
Marta Guerrero
Jesus Torres
Manuel Raga
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of AR053688A1 publication Critical patent/AR053688A1/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J1/00—Details of electrodes, of magnetic control means, of screens, or of the mounting or spacing thereof, common to two or more basic types of discharge tubes or lamps
    • H01J1/02—Main electrodes
    • H01J1/30—Cold cathodes, e.g. field-emissive cathode

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente se refiere a composiciones farmacéuticas utiles para el tratamiento de enfermedades dérmicas causadas por hongos y levaduras con inflamacion y/o asociadas a una infeccion bacteriana. Dichas composiciones contienen una cantidad terapéuticamente efectiva de sertaconazol, o sus sales, solvatos, isomeros farmacéuticamente aceptables o as mezclas correspondientes, y una cantidad terapéuticamente efectiva de al menos un compuesto seleccionado entre hidrocortisona, un éster de hidrocortisona farmacéuticamente aceptable, un compuesto de quinolona antibacteriano o las mezclas correspondientes.
ARP060100758A 2005-03-01 2006-03-01 Composicion farmaceurtica y su uso AR053688A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05101540A EP1698336A1 (en) 2005-03-01 2005-03-01 Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent

Publications (1)

Publication Number Publication Date
AR053688A1 true AR053688A1 (es) 2007-05-16

Family

ID=34938848

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100758A AR053688A1 (es) 2005-03-01 2006-03-01 Composicion farmaceurtica y su uso

Country Status (16)

Country Link
US (1) US20080166398A1 (es)
EP (2) EP1698336A1 (es)
JP (1) JP2008531640A (es)
KR (1) KR20070107806A (es)
CN (1) CN101137362A (es)
AR (1) AR053688A1 (es)
AU (1) AU2006219903A1 (es)
BR (1) BRPI0607561A2 (es)
CA (1) CA2598598A1 (es)
MX (1) MX2007010703A (es)
NO (1) NO20074945L (es)
PE (1) PE20061241A1 (es)
RU (1) RU2007136169A (es)
TW (1) TW200640452A (es)
UY (1) UY29402A1 (es)
WO (1) WO2006092374A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8057433B2 (en) 2004-07-08 2011-11-15 Drugtech Corporation Delivery system
WO2009114924A1 (en) * 2008-03-20 2009-09-24 Alda Pharmaceuticals Corp. Antiseptic compositions for the treatment of infections
EP2177208A1 (en) * 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Pharmaceutical topical compositions
CN103156862B (zh) * 2013-03-28 2015-04-29 孙国栋 一种复方伏立康唑滴耳剂及其制备方法
CN107205997A (zh) * 2015-02-13 2017-09-26 玛路弘株式会社 包含吡啶酮羧酸衍生物的外用制剂
MD3481370T2 (ro) * 2016-07-08 2021-08-31 Acraf Compoziție farmaceutică care conţine benzidamină
CN113520993B (zh) * 2021-07-30 2022-07-29 海南海神同洲制药有限公司 一种低粘度硝酸舍他康唑乳膏的制备方法及其制备的产品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407663A (en) * 1991-04-11 1995-04-18 Eisen; Drore Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
CN1152029C (zh) * 1998-04-06 2004-06-02 富山化学工业株式会社 喹喏酮羧酸衍生物及其盐
BR0212311A (pt) * 2001-09-04 2004-10-13 Trommsdorff Arzneimittel Emplastro para o tratamento de disfunções e distúrbios de unhas
US20030091540A1 (en) * 2001-10-16 2003-05-15 Nawaz Ahmad Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
AU2003302305A1 (en) * 2002-12-31 2004-07-22 Sachin S Bhagwat Benzoquinolizine-2-carboxylic acid-containing compositions
DK1635770T3 (da) * 2003-03-21 2009-08-03 Nexmed Holdings Inc Antifungal neglelak og anvendelsesmetode

Also Published As

Publication number Publication date
UY29402A1 (es) 2006-06-30
RU2007136169A (ru) 2009-04-10
US20080166398A1 (en) 2008-07-10
NO20074945L (no) 2007-11-21
CA2598598A1 (en) 2006-09-08
MX2007010703A (es) 2007-10-12
AU2006219903A1 (en) 2006-09-08
PE20061241A1 (es) 2006-11-13
WO2006092374A1 (en) 2006-09-08
EP1698336A1 (en) 2006-09-06
KR20070107806A (ko) 2007-11-07
JP2008531640A (ja) 2008-08-14
EP1858510A1 (en) 2007-11-28
CN101137362A (zh) 2008-03-05
BRPI0607561A2 (pt) 2009-09-15
TW200640452A (en) 2006-12-01

Similar Documents

Publication Publication Date Title
WO2006122160A3 (en) Compositions of bakuchiol and methods of making the same
AR053688A1 (es) Composicion farmaceurtica y su uso
AR050838A1 (es) Formulacion farmaceutica. para el tratamiento de una infeccion optica
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
CR10192A (es) Compuestos de amido y su uso como productos farmaceuticos
CR11683A (es) Piridinas y pirazinas como inhibidores de p13k
CL2013001654A1 (es) Compuestos derivados de 6-amino-2-fenilamino-1h-bencimidazol-5-carboxamida; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de las enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
CL2011003266A1 (es) Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras.
BRPI0813450B8 (pt) composto, formulação farmacêutica, e, usos do composto
AR053162A1 (es) Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma.
CL2013000304A1 (es) Compuestos derivados de 2-arilamino-bencimidazoles inhibidores de prostaglandina e2 (mpges-1); composicion farmaceutica que los comprende; compuestos intermediarios; uso en el tratamiento de enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
CL2007002641A1 (es) Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias.
CL2011001098A1 (es) Compuestos derivados de 4-fluoro-1h-isoindol-3-amina; inhibidores de b-secretasa (bace); composicion farmaceutica; y su uso para el tratamiento o prevencion de una patologia relacionada con la proteina beta amiloide tal como sindrome de down, alzheimer, demencia senil y demencia asociada con parkinson, entre otras.
WO2010108187A3 (en) Compounds and methods for treating mammalian gastrointestinal microbial infections
BRPI0518993A2 (pt) composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto
ECSP056006A (es) Composiciones farmacéuticas que comprenden una combinación de rapamicina o su derivado y pimecrolimus para el tratamiento de enfermedades inflamatorias e inmunológicamente mediadas
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
ATE529430T1 (de) Caspase-hemmer-propharmaka
ECSP055980A (es) Oxazolidinonas de indolona y derivados de las mismas
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
CR11208A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
UY30723A1 (es) Compuestos de biciclocarboxiamida sustituidos

Legal Events

Date Code Title Description
FB Suspension of granting procedure